Cargando…
Dexamethasone combined with berberine is an effective therapy for bleomycin-induced pulmonary fibrosis in rats
Pulmonary fibrosis (PF) is a heterogeneous pathological process in lung tissues with a considerable mortality rate. Currently, combination therapy represents an effective approach to treat PF. Dexamethasone (Dxs) and berberine (BBR) are widely applied to inhibit the progression of PF. Dxs plus peneh...
Autores principales: | Li, Li, Li, Qiuhong, Wei, Lei, Wang, Zhongfu, Ma, Wei, Liu, Fangying, Shen, Yanhua, Zhang, Shanfang, Zhang, Xiulian, Li, Huiping, Qian, Yechang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755270/ https://www.ncbi.nlm.nih.gov/pubmed/31555349 http://dx.doi.org/10.3892/etm.2019.7861 |
Ejemplares similares
-
Comprehensive analysis of gene-expression profile in chronic obstructive pulmonary disease
por: Wei, Lei, et al.
Publicado: (2015) -
FGF2 and FGFR2 in patients with idiopathic pulmonary fibrosis and lung cancer
por: Li, Li, et al.
Publicado: (2018) -
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023) -
Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Sheng, Hanjing, et al.
Publicado: (2022) -
Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023)